{ 120件 }
Chiho Oba-Yamamoto, Jun Takeuchi, Akinobu Nakamura, Ryoko Takikawa, Ayano Ozaki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia J Diabetes Investig, in press
IF: 3.761
Koki Chiba, Hiroshi Nomoto, Akinobu Nakamura, Kyu Yong Cho, Kumiko Yamashita, Yui Shibayama, Aika Miya, Hiraku Kameda, Yoshio Kurihara, Shin Aoki, Tatsuya Atsumi, Hideaki Miyoshi. SGLT2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.
J Diabetes Investig, in press
IF: 3.761
Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T. Inverse correlation between serum high-molecular-weight adiponectin and proinsulin level in a Japanese
population: the DOSANCO Health Study. J Diabetes Investig, in press
IF: 3.902
Takase T, Nakamura A, Miyoshi H, Koga M, Toyomaki A, Kusumi I, Kino R, Konishi Y, Kiso Y, Atsumi T.
Effects of Palmaria palmata on lipid metabolism and glycemic control in participants with hypercholesterolemia in a randomized double-blind placebo-controlled trial.
Phytother Res, in press
アメリカ内分泌学会 Outstanding abstract award 千葉 幸輝先生
令和元年度北海道科学技術奨励賞 中村 昭伸先生
フラテ研究奨励賞 亀田 啓先生
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa, Koshi Nakamura, Takafumi Nakagawa, Yasuo Terauchi, Akiko Tamakoshi, Tatsuya Atsumi
Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study
Journal of Diabetes Investigation, in press.
IF: 3.902
Kameda R, Nomoto H, Cho KY, Kawata S, Omori K, Takeuchi J, Nagai S, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Miyoshi H.
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicenter, prospective, randomized, open-label, blinded endpoint parallel-group comparison study.
BMJ Open. 2020
Nakamura A, Miyoshi H, Kameda H, Yamashita K, Kurihara Y.
Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
Diabetol Metab Syndr. 2020.